These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 34087455)
1. Expression of Transforming Growth Factor β1, Smad3, and Phospho-Smad3 in Somatotropinomas and Their Relationship to Tumor Behavior. Li Z; Li J; Shan X; Gui S; Li C; Zhang Y World Neurosurg; 2021 Sep; 153():e20-e27. PubMed ID: 34087455 [TBL] [Abstract][Full Text] [Related]
2. The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas. Zhenye L; Chuzhong L; Youtu W; Xiaolei L; Lei C; Lichuan H; Hongyun W; Yonggang W; Fei W; Yazhuo Z J Transl Med; 2014 Mar; 12():71. PubMed ID: 24636138 [TBL] [Abstract][Full Text] [Related]
3. HSV-1 infection suppresses TGF-beta1 and SMAD3 expression in human corneal epithelial cells. Nie Y; Cui D; Pan Z; Deng J; Huang Q; Wu K Mol Vis; 2008 Sep; 14():1631-8. PubMed ID: 18776948 [TBL] [Abstract][Full Text] [Related]
4. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Xu W; Wang LW; Shi JZ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172 [TBL] [Abstract][Full Text] [Related]
5. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study. Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778 [TBL] [Abstract][Full Text] [Related]
6. Smad2 and Smad3 as mediators of the response of adventitial fibroblasts induced by transforming growth factor β1. Ren M; Wang B; Zhang J; Liu P; Lv Y; Liu G; Jiang H; Liu F Mol Med Rep; 2011; 4(3):561-7. PubMed ID: 21468608 [TBL] [Abstract][Full Text] [Related]
7. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions. Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546 [TBL] [Abstract][Full Text] [Related]
8. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion. Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288 [TBL] [Abstract][Full Text] [Related]
9. Validation of immunohistochemistry for somatostatin receptor subtype 2A in human somatotropinomas: comparison between quantitative real time RT-PCR and immunohistochemistry. Wildemberg LE; Vieira Neto L; Costa DF; Nasciutti LE; Takiya CM; Alves LM; Gadelha MR J Endocrinol Invest; 2012 Jun; 35(6):580-4. PubMed ID: 21897115 [TBL] [Abstract][Full Text] [Related]
10. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway. Kim S; Lee J; Jeon M; Lee JE; Nam SJ Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Yeh YC; Wei WC; Wang YK; Lin SC; Sung JM; Tang MJ Am J Pathol; 2010 Oct; 177(4):1743-54. PubMed ID: 20709799 [TBL] [Abstract][Full Text] [Related]
12. Investigating dysregulation of TGF-β1/SMAD3 signaling in atopic dermatitis: a molecular and immunohistochemical analysis. Shafi T; Rasool Wani R; Hussain S; Bhat IA; Makhdoomi R; Bashir SA; Hassan I; Shah ZA Clin Exp Immunol; 2024 Apr; 216(2):192-199. PubMed ID: 38066678 [TBL] [Abstract][Full Text] [Related]
13. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells. Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434 [TBL] [Abstract][Full Text] [Related]
14. TGF-β1/Smad3 Signaling Pathway Suppresses Cell Apoptosis in Cerebral Ischemic Stroke Rats. Zhu H; Gui Q; Hui X; Wang X; Jiang J; Ding L; Sun X; Wang Y; Chen H Med Sci Monit; 2017 Jan; 23():366-376. PubMed ID: 28110342 [TBL] [Abstract][Full Text] [Related]
15. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas. Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585 [TBL] [Abstract][Full Text] [Related]
16. [The mechanism of transforming growth factor beta1 in myofibroblast differentiation]. Liu HX; Wang SW; Zhao CH; Liu Y; Li Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):986-9. PubMed ID: 17961388 [TBL] [Abstract][Full Text] [Related]
17. Indoxyl sulfate enhances p53-TGF-β1-Smad3 pathway in proximal tubular cells. Shimizu H; Yisireyili M; Nishijima F; Niwa T Am J Nephrol; 2013; 37(2):97-103. PubMed ID: 23363842 [TBL] [Abstract][Full Text] [Related]
18. Aberrant TGF-β1 signaling contributes to the development of primary biliary cirrhosis in murine model. Liu B; Zhang X; Zhang FC; Zong JB; Zhang W; Zhao Y World J Gastroenterol; 2013 Sep; 19(35):5828-36. PubMed ID: 24124327 [TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid attenuates the renal interstitial fibrosis lesion in rats but not by transforming growth factor-β1/Smad3 signaling pathway. Li ZY; Zhou TB; Qin YH; Su LN; Xu HL; Lei FY Ren Fail; 2013; 35(2):262-7. PubMed ID: 23176567 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor β1 promotes invasion of human JEG-3 trophoblast cells via TGF-β/Smad3 signaling pathway. Huang Z; Li S; Fan W; Ma Q Oncotarget; 2017 May; 8(20):33560-33570. PubMed ID: 28432277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]